1. Home
  2. ALTO vs TOI Comparison

ALTO vs TOI Comparison

Compare ALTO & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alto Ingredients Inc.

ALTO

Alto Ingredients Inc.

HOLD

Current Price

$4.95

Market Cap

349.4M

Sector

Industrials

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.45

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTO
TOI
Founded
2003
2007
Country
United States
United States
Employees
N/A
641
Industry
Major Chemicals
Medical/Nursing Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.4M
304.4M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ALTO
TOI
Price
$4.95
$3.45
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
119.51
N/A
EPS
0.16
N/A
Revenue
$917,927,000.00
N/A
Revenue This Year
$6.66
$30.15
Revenue Next Year
$0.43
$25.77
P/E Ratio
$30.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$2.02
52 Week High
$5.25
$4.88

Technical Indicators

Market Signals
Indicator
ALTO
TOI
Relative Strength Index (RSI) 62.39 59.40
Support Level $0.98 $3.35
Resistance Level $5.07 $3.74
Average True Range (ATR) 0.30 0.20
MACD -0.03 0.03
Stochastic Oscillator 69.23 65.22

Price Performance

Historical Comparison
ALTO
TOI

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: